Drug intelligence / Profile preview

Cestra Pregna Multi Tablets

Development stage: Unknown
Lead developer: Fidson HealthCare
Modality: Small Molecules
Administration: Oral

Overview

Cestra Pregna Multi Tablets is a comprehensive multivitamin and multimineral supplement developed and marketed by Fidson Healthcare. It is specifically formulated to meet the increased nutritional demands of women during preconception, pregnancy, and lactation. The formulation typically includes essential micronutrients such as folic acid, iron, iodine, and a spectrum of vitamins (A, B-complex, C, D, and E) designed to support maternal health, prevent neural tube defects, and promote healthy fetal development. As a branded generic product, it serves as a routine prenatal supplement to ensure adequate intake of nutrients that may be insufficient in the diet alone.

Brand names: Cestra Pregna Multi TabletsCestra Pregna Multi
Other names: Cestra Pregna Multi

Beyond the preview

Go deeper on Cestra Pregna Multi Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cestra Pregna Multi Tablets.

Explore the full profile